Dolby Laboratories (DLB) FY2020 results: revenue $1.2 billion, down 6.4% on the year
Dolby Laboratories, Inc. (DLB) reported revenue of $1.2 billion for fiscal 2020, the year ended 25 September 2020, down 6.4% on the year before. Net income was $231 million, down 9.3%, and diluted earnings per share $2.25. The figures are the company's own, from the 10-K it filed with the SEC on 16 November 2020.
Revenue
$1.2 billion
-6.4% on the year
FY2013FY2020
Operating margin
18.8%
20.7% a year earlier
FY2013FY2020
Net income
$231 million
-9.3% on the year
FY2013FY2020
Diluted EPS
$2.25
-7.8% on the year
FY2013FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
1,162
1,242
1,055
-6.4%
Cost of revenue
146
161
128
-8.9%
Gross profit
1,015
1,081
927
-6.1%
Gross margin
87.4%
87.0%
87.9%
Research and development
239
238
237
+0.5%
Operating income
219
257
184
-14.9%
Operating margin
18.8%
20.7%
17.4%
Interest expense
0.2
0.2
0.2
+9.4%
Pre-tax income
240
282
196
-15.1%
Income tax
8.1
26.8
154
-69.8%
Effective tax rate
3.4%
9.5%
78.5%
Net income
231
255
41.7
-9.3%
Net margin
19.9%
20.5%
4.0%
Diluted EPS
$2.25
$2.44
$0.39
-7.8%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
344
328
352
+4.9%
Capital expenditure
66.3
96.3
72.8
-31.1%
Free cash flow
278
231
279
+19.9%
Free cash flow margin
23.9%
18.6%
26.5%
Cash from investing
134
-56.2
78.1
Cash from financing
-208
-385
-134
Depreciation and amortisation
90.9
85.1
81.3
+6.8%
Share-based compensation
86.6
76.6
71.2
+13.1%
Buybacks
174
341
150
-49.0%
Dividends paid
88.6
77.5
66.2
+14.3%
Dividend per share
$0.88
$0.79
$0.67
+11.4%
Diluted shares, weighted
103m
105m
107m
-1.6%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
2,433
2,307
2,364
+5.4%
Non-controlling interest
5.8
5.7
6.6
+1.5%
Debt
0.0
0.0
0.0
Operating lease liabilities
65.3
0.0
n/a
Other liabilities
414
509
495
-18.7%
Total liabilities and equity
2,917
2,822
2,865
+3.4%
Fixed assets
542
537
514
+0.8%
Goodwill
337
335
328
+0.6%
Intangible assets
152
181
184
-15.7%
Investments
99.1
299
366
-66.8%
Cash and equivalents
1,072
797
918
+34.5%
Receivables
180
189
166
-4.6%
Inventory
25.6
32.3
26.2
-21.0%
Other assets
509
451
363
+12.8%
Total assets
2,917
2,822
2,865
+3.4%
10-K for the year ended 25 September 2020, filed 16 November 2020: the filing.